Cargando…
Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease
Autores principales: | Simone, Tessa M, Higgins, Stephen P, Higgins, Craig E, Lennartz, Michelle R, Higgins, Paul J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476021/ https://www.ncbi.nlm.nih.gov/pubmed/26110015 http://dx.doi.org/10.4172/1747-0862.1000125 |
Ejemplares similares
-
Small Molecule Targeting of PAI-1 Function: A New Therapeutic Approach for Treatment of Vascular Stenosis
por: Simone, Tessa M., et al.
Publicado: (2013) -
The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1
por: Samarakoon, Rohan, et al.
Publicado: (2019) -
Plasminogen activator inhibitor type 2 in breast cancer.
por: Duggan, C., et al.
Publicado: (1997) -
Structural insights into diverse modes of ICAM-1 binding by Plasmodium falciparum-infected erythrocytes
por: Lennartz, Frank, et al.
Publicado: (2019) -
PAI-1 Expression Is Required for HDACi-Induced Proliferative Arrest in ras-Transformed Renal Epithelial Cells
por: Higgins, Stephen P., et al.
Publicado: (2011)